REFERENCES
- Consensus conference. Perioperative red blood cell transfusion. JAMA 1988; 260: 2700–3.
- Keeling MM, Gray LA, Brink MA, Hillerich VK, Bland KI. Intraoperative autotransfusion. Experience in 725 consecutive cases. Ann Surg 1983; 197: 536–41.
- National Blood Resource Education Program. The use of autologous blood. JAMA 1990; 263: 414–7.
- Swanson DA, Lo RK, Lichtinger B. Predeposit auto-logous blood transfusions in patients undergoing irradiation and radical cystectomy. J Urol 1983; 130: 892–4.
- Canadian orthopedic perioperative erythropoietin study group. Effectiveness of perioperative recombinant hu-man erythropoietin in elective hip replacement. Lancet 1993; 341: 1227–32.
- Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, et al. Increased preoperative collection of autologous blood with recombinant humann erythropoietin therapy. New Eng J Med 1989; 321: 1163–8.
- Kyo S, Omoto R, Hirashima K, Eguchi S, Fujita T. Effect of human recombinant erythropoietin on reduc-tion homologous blood transfusion in open-heart surgery. A Japanese multicenter study. Circulation 1992; 86: 413–8.
- Levine EA, Rosen AL, Gould SA, Sehgel LR, Egrie JC, Browne JK, et al. Recombinant human erythropoietin and autologous blood donation. Surgery 1988; 104: 365–9.
- Mercuriali F, Gualtieri G, Sinigaglia L, Inghilleri G, Biffi E, Vinti A, et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994; 34: 501–6.
- Sans T, Bofill C, Joven J, Cliville X, Simo JM, Llobet X, et al. Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating auto-logous blood donation before orthopedic surgery. Transfusion 1996; 36: 822–6.
- Hirota Y, Okamura S, Kimura N, Shibuya T, Niho Y. Haematopoiesis in the aged as studied by in vitro colony assay. Eur J Haematol 1988; 40: 83–90.
- Lipshitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hamatopoiesis in man. Blood 1984; 63: 502–9.
- Fujita K, Kimura T, Saito K, Sangen H, Furuhata T, Uyama K, et al. Consecutive 1686 prostatectomies at 8 national hospitals. Jpn J Urol 1986; 77: 1631–6.
- Ihara H, Rimkus K, Takiuchi H, Koike H, Ogino T, Hosokawa S, et al. Autotransfusion in urologic sur-gery-Experience with transurethral resection. Jpn J Urol 1990; 81: 54–60.
- Jenkins AD, Mintz PD. Optimal blood use in genitour-inary surgery. J Urol 1981; 126: 497–9.
- Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC and Writing Committee. Trans-urethral prostatectomy: immediate and postoperative complications. A coopera-tive study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243–7.
- Sarma DP. Use of blood in elective surgery. JAMA 1980; 243: 1536–8.
- Thorpe AC, Cleary R, Coles J, Vernon S, Reynolds J, Neal DE. Death and complications following prosta-tectomy in 1400 men in the northern region of England. Br J Urol 1994; 74: 559–65.
- Agarwal M, Palmer J, Mufti GH. Transurethral resection for a large prostate-Is it safe? Br J Urol 1993; 72: 318–21.
- Goya N, Yanagisawa H, Osanai K, Asahina Y, Nakamura R, Nakazawa H, et al. Autologous blood transfusion aided with erythropoietin in transurethral resection of the prostate. Jpn J Urol 1991; 82: 1978–85.
- Goodnough LT, Vizmeg K, Riddell IV J, Soegiarso RW. Discharge hematocrit as clinical indicator for blood transfusion audit in surgery patients. Transfusion Medicine 1994; 4: 35–44.
- Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Internal Med 1991; 229: 125–30.
- Eschbach JVV, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of combined Phase I and II clinical trials. N Engl J Med 1987; 316: 73–8.
- Souillard A, Audran M, Bressolle F, Gareau R, Duvallet A, Chanal JL. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control. Br J Pharmacol 1996; 42: 355–64.